Third Rock Ventures III L.P. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Sale |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Third Rock Ventures III L.P. | 186,423 0.400% |
-5,279,211 (-96.59%) |
Filing |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Third Rock Ventures III L.P. | 5,465,634 14.200% |
-3,953,663 (-41.97%) |
Filing |